혈장분리교환술 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 절차별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Plasmapheresis Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 2.6 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global plasmapheresis market is poised for significant growth, driven by various macroeconomic and microeconomic factors. Increasing healthcare expenditures, particularly in regions like the Middle East and Asia Pacific, are creating new opportunities for market players, emphasizing advanced medical care. A growing awareness of treatment options for immune system disorders such as myasthenia gravis and systemic lupus erythematosus is further propelling market demand. Advances in plasmapheresis technology and the expansion into veterinary healthcare are expected to positively influence the market landscape. With autoimmune diseases becoming more prevalent due to environmental factors and population growth, plasmapheresis services are experiencing double-digit demand increases. The North American sector leads in market share and offers substantial growth potential in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segments Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth driven by an increase in the prevalence of various autoimmune disorders, such as thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and others. As awareness of these conditions rises, coupled with an emphasis on enhancing healthcare infrastructure, the demand for plasmapheresis therapy is expected to escalate. The growing investment in healthcare across multiple regions is supporting the wider adoption of advanced treatment options. In particular, developments in regions like the Middle East and Africa, along with Asia Pacific, are likely to play a significant role in driving the demand for innovative healthcare solutions, further boosting the plasmapheresis market.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces notable challenges stemming from concerns related to potential side effects associated with the procedure. Patients may experience issues such as decreased arterial blood pressure, irregular heart rhythms, temporary increases in body temperature, and sensations of tingling or numbness. Although these adverse effects are generally considered mild, they can significantly impact the willingness of healthcare providers and patients to embrace plasmapheresis as a viable treatment option. As a result, stakeholders in the market may encounter hurdles related to declining usage rates of plasmapheresis therapies, which could hinder overall market growth and adoption efforts.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is experiencing significant growth as the demand for plasma-derived therapies rises, driven by an increasing prevalence of chronic diseases such as anemia, gastrointestinal disorders, and cancer. This surge is further propelling the need for efficient blood donation practices. Healthcare organizations are actively innovating and enhancing plasmapheresis equipment, particularly apheresis machines, aiming to improve the efficacy and safety of the procedure. Furthermore, the growing awareness among patients and healthcare professionals about the benefits of plasmapheresis is contributing to its wider acceptance. Overall, these dynamics indicate a robust expansion trajectory for the plasmapheresis market globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Membrane Filtration
• Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Photopheresis
• Ldl Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Source Plasma Collection
• Therapeutic Plasmapheresis
• Immunology
• Neurology
• Hematology
• Critical Care
• Oncology
• Rheumatology & Orthopedics
• Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Blood Banks & Plasma Collection Centers
• Hospital & Clinics
• Biopharmaceutical Companies
• Other End User

Global Plasmapheresis Market Size & CAGR (2026-2033)

• North America (Product, Technology, Procedure, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Procedure, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Procedure, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Procedure, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Procedure, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin Blood Supply Foundation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations